The seventh batch of national mining official announcement!

Among them, the sales of nifedipine sustained-release and controlled-release dosage form, meropenem injection and omeprazole injection all exceeded 5 billion yuan

Judging from the number of over-evaluated companies, omeprazole injection, tenofovir alafenamide oral normal-release formulation, clindamycin phosphate injection, cefixime oral normal-release formulation, and nifedipine sustained-release formulation are five.

The domestic patent of tenofovir alafenamide oral normal-release dosage form has expired in July 2021, and the original research manufacturer Gilead will still monopolize the market in the first half of 2021

From the perspective of enterprises, among multinational pharmaceutical companies, Pfizer leads with 5 varieties, and Roche and Novartis are both 4

Among the domestic enterprises, the qualified ones are still mainly large enterprises.

Anti-tumor and antibacterial drugs attract attention in the collection of injections

From the perspective of therapeutic areas, among the seventh batch of national harvests, anti-tumor and antibacterial drugs are the highlight

  Specifically, a total of 7 anti-tumor drugs were selected in the seventh batch of national procurement

  Under the further influence of centralized procurement and the epidemic situation, in 2020, the terminal systemic antibacterial drugs of Chinese public medical institutions will drop by 26.

  Among the seventh batch of antibacterial drugs adopted by the country, according to data from Minet.

This year and next year, it may cover 200+ chemical drugs

  Among them, oseltamivir oral normal-release dosage form belongs to the basic drug specification, and needs to be reasonably reported according to the epidemic development trend of the disease; meropenem injection, micafungin injection, tigecycline injection, cefepime injection The dosage forms belong to the special-use grade Antibacterial drugs; edaravone injection form belongs to the first batch of national key monitoring rational drug catalogue (chemical drugs and biological products)

  So far, China has carried out six batches of national centralized drug procurement, and found that, divided by the sixth batch of national procurement of insulin as the procurement object, the first five batches were all carried out around chemical drugs, covering a total of 218 varieties, and the average decline was basically the same.

  Some responsible persons of injection enterprises believe that for enterprises, winning or not winning the bid is a test of life and death

  The National Medical Security Work Conference held in mid-January this year pointed out that in 2022, the normalization and institutionalization of centralized drug procurement will be carried out.
Promote the pattern of centralized procurement in an all-round way, and further reduce the sales space with gold
.
  

  Gong Bo, director of the Pharmaceutical Price and Bidding and Procurement Department of the Shanghai Medical Insurance Bureau, once told the media that there are now more than 620 clinical drugs, which can cover 80% of all purchases
.
Among the more than 620 kinds of medicines, chemicals account for about 490 kinds.
It is hoped that in the near future, all 490 kinds of chemicals will be included in the centralized procurement as much as possible
.
This means that the remaining more than 270 kinds of chemical drugs may be fully included in the national centralized procurement list within 2 years
.
The industry expects that two batches will be launched each year this year and next year to complete the centralized procurement of these drugs, and the chemical drug market will accelerate the overall reshuffle
.